GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Net Change in Cash

U-Neuron Biomedical (ROCO:6973) Net Change in Cash : NT$25.94 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

U-Neuron Biomedical's Net Change in Cash for the six months ended in Dec. 2023 was NT$26.83 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was NT$25.94 Mil.

U-Neuron Biomedical Net Change in Cash Historical Data

The historical data trend for U-Neuron Biomedical's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Net Change in Cash Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Change in Cash
- 48.82 -24.50 25.94

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Net Change in Cash - -28.85 4.35 -0.89 26.83

U-Neuron Biomedical Net Change in Cash Calculation

U-Neuron Biomedical's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-53.206+-306.451+385.598+0
=25.94

U-Neuron Biomedical's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-18.24+47.273+-2.201+0
=26.83

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$25.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Net Change in Cash Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Net Change in Cash
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
https://en.u-neuron.com
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines